Last reviewed · How we verify
Human Derived anti-BCMA CAR-T Injection
At a glance
| Generic name | Human Derived anti-BCMA CAR-T Injection |
|---|---|
| Also known as | BCMA CAR-T |
| Sponsor | Hrain Biotechnology Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- To Evaluate the Safety and Efficacy of Human Derived Anti-BCMA CAR-T Injection for Subjects with R/R MM (EARLY_PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |